Titre du document / Document title
Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion
Auteur(s) / Author(s)
WIEBE E. R.
(1) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Department of Family Practice, University of British Columbia, CANADA
Résumé / Abstract
OBJECTIVE: This study was undertaken to compare oral to injected methotrexate with respect to effectiveness, side effects, and acceptability. STUDY DESIGN: One hundred women in an urban primary care practice were randomly assigned in phase 1 to receive 50 mg/m
2 methotrexate by either the oral or the injected route. In phase 2 another 87 women were allowed to choose between the oral and injected routes. In both phases and in all groups the methotrexate was followed 5 to 7 days later by misoprostol administered vaginally by the patient. The main outcome was the success rate (the number whose pregnancies aborted without surgery); other outcomes included side effects and acceptability. RESULTS: There were no differences in rates of success, side effects, or acceptability between groups receiving oral and injected methotrexate. Among the women in phase 2 the oral form was chosen by 57.5%. CONCLUSION: This study indicates that for medical abortions induced with methotrexate and misoprostol it is possible to offer both the oral and injected routes of methotrexate without sacrificing efficacy and that about half of the women offered a choice will choose the oral route.
Revue / Journal Title
American journal of obstetrics and gynecology
ISSN 0002-9378
CODEN AJOGAH
Source / Source
1999, vol. 181, n
o1, pp. 149-152 (22 ref.)
Langue / Language
Anglais
Editeur / Publisher
Elsevier, Philadelphia, PA, ETATS-UNIS
(1920)
(Revue)
Mots-clés anglais / English Keywords
Induced abortion ;
Methotrexate ;
Chemotherapy ;
Treatment ;
Treatment efficiency ;
Toxicity ;
Comparative study ;
Route of administration ;
Oral administration ;
Intramuscular administration ;
Misoprostol ;
Combined treatment ;
Canada ;
Adult ;
Female ;
Prostaglandin derivatives ;
North America ;
America ;
Human ;
Mots-clés français / French Keywords
Avortement provoqué ;
Méthotrexate ;
Chimiothérapie ;
Traitement ;
Efficacité traitement ;
Toxicité ;
Etude comparative ;
Voie administration ;
Voie orale ;
Voie intramusculaire ;
Misoprostol ;
Traitement associé ;
Canada ;
Adulte ;
Femelle ;
Prostaglandine dérivé ;
Amérique du Nord ;
Amérique ;
Homme ;
Mots-clés espagnols / Spanish Keywords
Aborto provocado ;
Metotrexato ;
Quimioterapia ;
Tratamiento ;
Eficacia tratamiento ;
Toxicidad ;
Estudio comparativo ;
Vía administración ;
Vía oral ;
Vía intramuscular ;
Misoprostol ;
Tratamiento asociado ;
Canada ;
Adulto ;
Hembra ;
Prostaglandina derivado ;
America del norte ;
America ;
Hombre ;
Localisation / Location
INIST-CNRS, Cote INIST : 3053, 35400008924210.0260
Nº notice refdoc (ud4) : 1887303